IP Library Granted Patent US 8,715,924
Granted Patent B2
US 8,715,924 · App. 11/808,835 · Granted May 6, 2014

Process for determining the concentration of nucleic acids

Inventors: Walter Gumbrecht (Herzogenaurach, DE); Jörn Mosner (Erlangen, DE); Sebastian Schmidt (Weisendorf, DE)
Assignee: Siemens Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,715,924
App. No.
11/808,835
Granted
May 6, 2014
Kind
B2
Abstract

A process is disclosed for determining the concentration of nucleic acids in a sample in a microfluidic device. In at least one embodiment, the method includes a) introducing the sample into a first chamber, b) carrying out a number of cycles of an amplification reaction to be carried out in cycles for amplifying nucleic acids, c) transferring a defined volume which is a fraction of the volume of the first chamber and which has amplified nucleic acids into a second chamber and replacing the transferred defined volume with fresh reagents for the amplification reaction, d) determining the concentration of the amplified nucleic acids in a second chamber equipped with an element to determine concentrations, and e) repeating steps b)-d) until a concentration of the amplified nucleic acids which is within a range is determined in the second chamber. An arrangement is further disclosed.

Claims (30)

1. A process for determining a concentration of nucleic acids in a sample in a microfluidic device with a first chamber and a second chamber, comprising the following steps:

a) introducing the sample into the first chamber via a first supply channel connected to the first chamber and providing a first supply of reagents for an amplification reaction, which is to be carried out in cycles, into said first chamber via a second supply channel connected to the first chamber;

b) carrying out a number of said cycles of said amplification reaction such that the nucleic acids are amplified;

c) transferring a defined volume from the first chamber, which is a fraction of a total sample volume in the first chamber and which has said amplified nucleic acids, into said second chamber via a channel connecting the first chamber to the second chamber and simultaneously replacing the transferred defined volume by providing a fresh, second supply of the reagents for said amplification reaction in the first chamber by supplying the fresh, second supply of the reagents through the second supply channel using a volume transfer device located outside of the supply channel, wherein a remaining fraction of the total sample volume remains in the first chamber for subsequent amplification;

d) determining said concentration of the amplified nucleic acids in the second chamber equipped with a device for determining said concentration; and

e) repeating steps b)-d) until said determined concentration of the amplified nucleic acids in said second chamber is within a set range,

wherein said set range is a measurement range of said device for determining said concentrations.

2. The process as claimed in claim 1 , wherein said device for determining said concentration includes a microarray having position-specifically immobilized capture oligonucleotides for binding the amplified nucleic acids.

3. The process as claimed in claim 1 , wherein the concentration of the amplified nucleic acids bound is determined utilizing a label.

4. The process as claimed in claim 3 , wherein the label is an optical label.

5. The process as claimed in claim 3 , wherein the label is an enzymatic label.

6. The process as claimed in claim 5 , wherein the label catalyzes an enzymatic reaction which is optically detectable.

7. The process as claimed in claim 5 , wherein the label catalyzes an enzymatic reaction is electrochemically detectable.

8. The process as claimed in claim 7 , wherein electrochemical detection is by way of measuring currents enhanced by way of redox cycling.

9. The process as claimed in claim 1 , wherein the concentration of nucleic acids is calculated by at least one of:

on the basis of a volume ratio of the transferred defined volume to the total sample volume, and

on the basis of a total of the number of amplification cycles carried out.

10. The process as claimed in claim 1 , wherein the amplification reaction is a polymerase chain reaction.

11. The process as claimed in claim 2 , wherein the concentration of the amplified nucleic acids bound is determined utilizing a label.

12. The process as claimed in claim 11 , wherein the label is an optical label.

13. The process as claimed in claim 11 , wherein the label is an enzymatic label.

14. The process as claimed in claim 1 , wherein the determination of said concentration of the amplified nucleic acids includes quantifying said concentration of the amplified nucleic acids using the device for determining said concentration.

15. A process for determining a concentration of nucleic acids in a sample in a microfluidic device with a first chamber and a second chamber, comprising the following steps:

a) introducing the sample into the first chamber via a first supply channel connected to the first chamber and providing a first supply of reagents for an amplification reaction, which is to be carried out in cycles, into said first chamber via a second supply channel connected to the first chamber;

b) carrying out a number of said cycles of said amplification reaction such that the nucleic acids are amplified;

c) transferring a defined volume from the first chamber, which is a fraction of a total sample volume in the first chamber and which has said amplified nucleic acids, into said second chamber via a channel connecting the first chamber to the second chamber and simultaneously replacing the transferred defined volume by providing a fresh, second supply of the reagents for said amplification reaction in the first chamber by supplying the fresh, second supply of the reagents through the second supply channel using a volume transfer device located outside of the microfluidic device, wherein a remaining fraction of the total sample volume remains in the first chamber for subsequent amplification;

d) determining said concentration of the amplified nucleic acids in the second chamber equipped with a device for determining said concentration; and

e) repeating steps b)-d) until said determined concentration of the amplified nucleic acids in said second chamber is within a set range,

wherein said set range is a measurement range of said device for determining said concentrations, and

wherein a known nucleic acid with a known starting concentration (internal standard) is added to the sample.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2014
From: SIEMENS AG
To: BOEHRINGER INGELHEIM VETMEDICA GMBH
Reel/Frame 033190/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2007
From: GUMBRECHT, WALTER; MOSNER, JORN; SCHMIDT, SEBASTIAN
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 019810/0895 →
Priority Claims (1)
DE 10 2006 027 675 · Jun 14, 2006 · national
Continuity (1)
Related Publication 20070298429A1 · Dec 27, 2007